Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gevokizumab in inflammatory erosive osteoarthritis of the hand
NCT01882491Phase 2Completed
- Sponsor
- XOMA
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of gevokizumab in erosive osteoarthritis (EOA), sponsored by XOMA. Started May 2013; status: completed.
02
Drugs
gevokizumab
03
Conditions
erosive osteoarthritis (EOA)
Beyond the preview
Go deeper on NCT01882491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882491.